The Concept of Flexibility – Injectable Drug Products from Clinical to Commercial
With various processes and filling lines, and an overall annual capacity of ~100 million units, our Injectable platform offers the flexibility to support multiple programs and
customers in parallel, at any scale and stage of drug development & commercialization.
We offer you a broad spectrum of injectable services starting from early formulation development to full commercial scale, covering both terminal sterilization & aseptic filling technologies for Pre-filled Syringes (PFS), vials, ampoules, cartridges and lyophilized vials, with a range of filling volumes including the capability for combination products.
Your benefit expands to the seamless tech transfer of your API project (either Peptide or Small Molecule) within our facility network, which spans the manufacturing of drug substances to drug products, including packaging, labeling and clinical trial kit management services.
Read more about our capabilities for sterile injectable drug products.
